Thus, similar to the MAZERATI system, our endogenous knock-in system allows us to rapidly dissect the melanocyte-specific function of both oncogenes (BRAFV600E) and putative tumor suppressors (tp53, ptena/b), while avoiding pleiotropic effects of global tumor suppressor loss. The gene discussed is TP53; the disease is neoplasm.